The Zero-Price Conundrum: Exploration of Scenarios Where a Clinically Effective New Drug Might Not Be Cost-Effective at Zero Price.
Deirdre MladsiChristine L BarnettGregory MaderT Alexander Russell-SmithAig UnuigbeTim BellPublished in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (2023)
The zero-price dilemma may arise more frequently as the number of drugs in high-cost disease areas continues to grow. As cost-effectiveness methods evolve, there is the opportunity to develop robust solutions that can be applied consistently.